| 861 - 880 of 1000 Benin Republic News Headlines |
Page 44 of 50 Pages |
BAYER SELLS DIAGNOSTIC BUSINESS TO SIEMENS
FDAnews
- Sunday, August 13, 2006
Bayer Diagnostics India Ltd will become a part of the Siemens Group, following the worldwide sale of the Bayer Group's diagnostic business to Simens AG for a price of 4.2 billion
... more
|
INSITE VISION SUBMITS NDA FOR AZASITE IN THE TREATMENT OF BACTERIAL CONJUNCTIVITIS WITH U.S. FDA
FDAnews
- Sunday, August 13, 2006
Thursday, InSite Vision, Inc., an ophthalmic products company, revealed the submission of a New Drug Application or NDA with the U.S. Food and Drug Administration for AzaSite indicated in the treatment of bacterial
... more
|
NOVEN CONFIRMS AVAILABILITY OF DAYTRANA METHYLPHENIDATE TRANSDERMAL SYSTEM
FDAnews
- Sunday, August 13, 2006
Noven Pharmaceuticals, Inc. today confirmed that Shire plc has launched Daytrana (methylphenidate transdermal system), the first and only transdermal medication approved to treat the symptoms of Attention Deficit Hyperactivity Disorder (ADHD) in children aged six to twelve years, and that the product is now available in retail
... more
|
CYTOGENIX RECEIVES THE 2006 FROST & SULLIVAN TECHNOLOGY INNOVATION AWARD FOR SYNDNA
FDAnews
- Sunday, August 13, 2006
Frost & Sullivan, the leading global growth consulting company has chosen CytoGenix as the recipient of the 2006 Technology Innovation Award in biotechnology processing for the development of the synDNA large-scale DNA production
... more
|
BAXTER HEALTHCARE SIGNS CONSENT DECREE FOR CGMP VIOLATIONS IN MAKING INFUSION PUMPS
FDAnews
- Sunday, August 13, 2006
Baxter Healthcare has signed a consent decree with the FDA related to violations of current good manufacturing practices (cGMPs) in making two brands of infusion pumps, the agency said June
... more
|
HOUSE BILL PROPOSES MORATORIUM ON PAYMENT CUTS FOR MEDICARE DIAGNOSTIC SERVICES
FDAnews
- Sunday, August 13, 2006
A House bill would place a two-year moratorium on Medicare payment cuts for diagnostic imaging that were included in the 2005 Deficit Reduction Act (DRA) passed by Congress in
... more
|
FDA POSTS INFORMATION ON NEWLY APPROVED HCV DIAGNOSTIC TESTS
FDAnews
- Sunday, August 13, 2006
The FDA June 30 posted information on the Architect Anti-HCV, Anti-HCV Calibrator and Anti-HCV Controls diagnostic tests approved June
... more
|
ABAXIS ANNOUNCES FORMAL DISTRIBUTION AGREEMENT WITH HENRY SCHEIN FOR THE MEDICAL MARKET
FDAnews
- Sunday, August 13, 2006
Abaxis, Inc., a medical products company manufacturing point-of-care blood analysis systems, announced today that the Company has entered into a formal distribution agreement with Henry Schein, Inc, the largest provider of healthcare products and services to office-based practitioners in the combined North American and European
... more
|
VISIONCARE IMT VISUAL PROSTHETIC DEVICE GOES TO OPHTHALMIC PANEL JULY 14
FDAnews
- Sunday, August 13, 2006
The Ophthalmic Devices advisory panel will meet July 14 to make recommendations and vote on VisionCare's PMA for an implantable miniature
... more
|
APPLERA AND BECKMAN COULTER ANNOUNCE FINAL AGREEMENT ON SETTLEMENT
FDAnews
- Sunday, August 13, 2006
Applera Corporation and Beckman Coulter, Inc. jointly announced today that they have entered into a definitive agreement to resolve all outstanding legal disputes between the parties regarding claims to certain Beckman Coulter patented capillary electrophoresis technology and instrumentation technology and Applera's allegations of breach of contract of certain licensed
... more
Advertisement
|
FOR MEN, CATHETER TYPE MAKES A HUGE DIFFERENCE IN URINARY INFECTION RISK, STUDY FINDS
FDAnews
- Sunday, August 13, 2006
It's one of the things about a hospital stay that men loathe, and that infectious bacteria love: the urinary
... more
|
ALPHATEC HOLDINGS, INC. PROVIDES LITIGATION UPDATE
FDAnews
- Sunday, August 13, 2006
Alphatec Holdings, Inc., a medical device company that provides customized products and a broad suite of spine fusion solutions, announced today that it has executed a settlement agreement with Benchmark Medical Holdings, Inc. that relieves both parties of all obligations related to prior severance and promissory note agreements between Benchmark
... more
|
GERMANY BEGINS RISK SURVEY ON NANOTECHNOLOGY
FDAnews
- Sunday, August 13, 2006
The German Federal Institute of Risk Assessment (BfR) has commissioned the University of Stuttgart to conduct the survey on the risks of nanotechnological applications in personal care, food and other everyday items, according to a report by the
... more
|
Liberia needs $1 bln to rebuild power grid
Topix
- Sunday, August 13, 2006
Liberia will need $1 billion to rebuild a power network ruined by 14 years of civil war, experts from the Economic Community of West African States said on
... more
|
DEVICE INDUSTRY FULLY ENGAGED IN U.S.-KOREA FREE TRADE NEGOTIATIONS
FDAnews
- Sunday, August 13, 2006
An initial round of trade negotiations between the U.S. and South Korea in early June has "significant implications" for the device and diagnostics industry, AdvaMed said June
... more
|
GAO REPORT DESCRIBES MEDICAID FINANCIAL MANAGEMENT PROBLEMS AT CMS
FDAnews
- Sunday, August 13, 2006
The Government Accountability Office (GAO) July 3 released its findings on Medicaid financial management at the Centers for Medicare & Medicaid
... more
|
N.E. AND OTHER MEDTECH REGIONS WOULD BE HIT HARD BY PROPOSED NIH CUTS, BUSINESS LEADER SAYS
FDAnews
- Sunday, August 13, 2006
A bill recently approved by a House panel has raised concerns in the medical technology industry that research programs sponsored by the National Institutes of Health (NIH) will suffer funding
... more
|
ZIMMER HOLDINGS RECEIVES U.S. REGULATORY APPROVAL TO BEGIN SALE OF CERAMIC HIP REPLACEMENTS
FDAnews
- Sunday, August 13, 2006
Zimmer Holdings, Inc., a leader in the orthopaedics industry, announced today that it has received approval of its Premarket Approval Application(PMA) from the United States Food and Drug Administration (FDA) to market the Trilogy AB(R) Ceramic-on-Ceramic Acetabular
... more
|
BD DIAGNOSTICS ANNOUNCES AGREEMENT WITH BIOREFERENCE LABORATORIES FOR BD VIPER ROBOTIC INSTRUMENTATION AND MOLECULAR TESTING OF SEXUALLY TRANSMITTED INFECTIONS
FDAnews
- Sunday, August 13, 2006
BD Diagnostics, a segment of BD (Becton, Dickinson and Company), today announced the signing of an agreement with BioReference Laboratories of Elmwood Park, NJ for BD to supply BRLI with instrumentation and reagents for testing and diagnosis of sexually transmitted infections
... more
|
CORGENIX LAUNCHES DIAGNOSTIC TEST FOR ASPIRIN EFFECTIVENESS
FDAnews
- Sunday, August 13, 2006
Corgenix Medical Corporation has released for international sale its newest diagnostic product to be used in the fight against cardiovascular disease. The Company's AspirinWorks(R) Test Kit was launched at the 52nd Annual Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, held June 28 through July 1,
... more
|